BRUCE EDSON: Open Payments
NPI 1528129913 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,458 in 162 payments from 21 companies in 2025. Trend: 2023 $4,312 · 2024 $3,659 · 2025 $4,458
Food & beverage: $4,458
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $560 |
| Axsome Therapeutics, Inc. | 13 | $530 |
| Neurocrine BioSciences, Inc. | 12 | $515 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $513 |
| Otsuka America Pharmaceutical, Inc. | 13 | $306 |
| Vanda Pharmaceuticals Inc. | 9 | $267 |
| Lundbeck LLC | 7 | $206 |
| Janssen Pharmaceuticals, Inc | 8 | $195 |
| Noven Therapeutics, LLC | 8 | $189 |
| Alkermes, Inc. | 7 | $157 |
Products named: AUSTEDO XR, INGREZZA, CAPLYTA, REXULTI, Auvelity, SPRAVATO, Xelstrym, HETLIOZ.
Industry payments across FL — which companies pay providers there.
